| New insights into the genetic etiology of Alzheimer’s disease and related dementias C Bellenguez, F Küçükali, IE Jansen, L Kleineidam, S Moreno-Grau, ... Nature genetics 54 (4), 412-436, 2022 | 1333 | 2022 |
| Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores I De Rojas, S Moreno-Grau, N Tesi, B Grenier-Boley, V Andrade, ... Nature communications 12 (1), 3417, 2021 | 222 | 2021 |
| New insights on the genetic etiology of Alzheimer’s and related dementia C Bellenguez, F Küçükali, I Jansen, V Andrade, S Moreno-Grau, N Amin, ... MedRxiv, 2020.10. 01.20200659, 2020 | 74 | 2020 |
| COVID‐19 in hospitalized HIV‐positive and HIV‐negative patients: A matched study C Díez, J Del Romero‐Raposo, R Mican, JC López, JR Blanco, ... HIV medicine 22 (9), 867-876, 2021 | 36 | 2021 |
| Severe immunosuppression is related to poorer immunogenicity to SARS-CoV-2 vaccines among people living with HIV A Corma-Gómez, M Fernández-Fuertes, E García, A Fuentes-López, ... Clinical Microbiology and Infection 28 (11), 1492-1498, 2022 | 33 | 2022 |
| High rate of major drug–drug interactions of lopinavir–ritonavir for COVID-19 treatment J Macias, A Pinilla, FA Lao-Dominguez, A Corma, E Contreras-Macias, ... Scientific Reports 10 (1), 20958, 2020 | 23 | 2020 |
| HIV infection does not increase the risk of liver complications in hepatitis C virus-infected patient with advanced fibrosis, after sustained virological response with direct … A Corma-Gómez, L Morano, F Téllez, A Rivero-Juárez, LM Real, ... Aids 33 (7), 1167-1174, 2019 | 21 | 2019 |
| Liver stiffness at the time of sustained virological response predicts the clinical outcome in HIV/HCV-coinfected patients with advanced fibrosis treated with direct-acting … S Spain | 21 | 2019 |
| Liver stiffness at the time of sustained virological response predicts the clinical outcome in people living with human immunodeficiency virus and hepatitis C virus with … A Corma-Gómez, J Macías, F Téllez, C Freyre-Carrillo, L Morano, ... Clinical Infectious Diseases 71 (9), 2354-2362, 2020 | 19 | 2020 |
| Reduced neutralizing antibody response to SARS‐CoV‐2 vaccine booster dose in people living with HIV with severe immunosuppression A Corma‐Gómez, M Fernández‐Fuertes, L Viñuela, C Domínguez, ... Journal of Medical Virology 95 (3), e28602, 2023 | 11 | 2023 |
| Similar incidence of coronavirus disease 2019 (COVID-19) in patients with rheumatic diseases with and without hydroxychloroquine therapy J Macías, P González-Moreno, E Sánchez-García, R Morillo-Verdugo, ... PLoS One 16 (4), e0249036, 2021 | 11 | 2021 |
| Lower probability of persistence of total anti-SARS-CoV-2 antibodies after COVID-19 among people living with HIV J Macías, M Fernández-Fuertes, N Oliver, A Corma-Gómez, LM Real, ... Clinical Microbiology and Infection 28 (5), 755-756, 2022 | 9 | 2022 |
| Higher relapse rate among HIV/HCV-coinfected patients receiving sofosbuvir/ledipasvir for 8 vs 12 weeks A Corma-Gómez, J Macías, DM Muñoz, F Téllez, R Granados, LE Morano, ... Journal of Infection 79 (1), 30-35, 2019 | 9 | 2019 |
| Predictors of low‐level HIV viraemia and virological failure in the era of integrase inhibitors: A Spanish nationwide cohort H Álvarez, M Rava, C Martínez, J Portilla, J Peraire, A Rivero, M Cervero, ... HIV medicine 23 (8), 825-836, 2022 | 8 | 2022 |
| Human immunodeficiency virus (HIV) infection is associated with lower risk of hepatocellular carcinoma after sustained virological response to direct-acting antivirals in … A Corma-Gómez, J Macías, JR Lacalle-Remigio, F Téllez, L Morano, ... Clinical Infectious Diseases 73 (7), e2109-e2116, 2021 | 8 | 2021 |
| Similar prevalence of hepatic steatosis among patients with chronic hepatitis C with and without HIV coinfection M Fernandez-Fuertes, J Macías, A Corma-Gómez, P Rincón, N Merchante, ... Scientific Reports 10 (1), 6736, 2020 | 7 | 2020 |
| Hepatitis C virus infection in Spain: Challenges in the track to elimination. A Corma-Gómez, JA Pineda Enfermedades infecciosas y microbiologia clinica (English ed.) 37 (4), 219-221, 2019 | 7 | 2019 |
| High efficacy of glecaprevir/pibrentasvir for HCV-infected individuals with active drug use A Gonzalez-Serna, J Macias, A Corma-Gomez, F Tellez, J Cucurull, ... Journal of Infection 85 (3), 322-326, 2022 | 6 | 2022 |
| Liver stiffness–based strategies predict absence of variceal bleeding in cirrhotic hepatitis C virus–infected patients with and without human immunodeficiency virus coinfection … A Corma-Gómez, J Macías, L Morano, A Rivero, F Téllez, MJ Ríos, ... Clinical Infectious Diseases 72 (5), e96-e102, 2021 | 6 | 2021 |
| A genome‐wide association study on low susceptibility to hepatitis C virus infection (GEHEP012 study) LM Real, M Fernández‐Fuertes, ME Sáez, A Rivero‐Juárez, M Frías, ... Liver International 39 (10), 1918-1926, 2019 | 6 | 2019 |
